Nalbuphine (a recalls

The FDA has published 1 recall involving Nalbuphine (a since 2023. The latest was reported on 22 Feb 2023. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2023

Last 12 months0reported

Class I00% of total

Ongoing0latest 22 Feb 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why nalbuphine (a is recalled

Sterility1100%

Companies

Sentara Infusion Services1100%

By year

20231100%

All nalbuphine (a recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
22 Feb 2023Drug	CLASS II	Nalbuphine (a) 1.5MG IN NS, (b) 2.5MG IN NS, Syringe, pain recalled	Sentara Infusion Services	Sterility	Nationwide

Should you stop taking Nalbuphine (a?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.